PR NEWSWIRE

Previous Stories

Illumina reaffirms commitment to the National Project of Bio Big Data in Korea

Sep 20 2021 - PR NewsWire

MELBOURNE, Australia, Sept. 20, 2021 /PRNewswire/ – Illumina, Inc. (NASDAQ: ILMN) today announced that the National Project of Bio Big Data in…


Discover Australian businesses with a progressive Customer-first approach at Kalkine Media’s INVEST NEST Webinar on September 23

Sep 18 2021 - PR NewsWire

SYDNEY, Sept. 18, 2021 /PRNewswire/ — Kalkine Media is organising the next edition of the "INVEST NEST" webinar series, titled…


Keep charging, stop changing: Crown presents its new V-Force lithium-ion technology

Sep 17 2021 - PR NewsWire

SYDNEY, Sept. 17, 2021 /PRNewswire/ – Crown Equipment Corporation, one of the world’s largest material handling companies, has launched its own…


Panduit (TM) Australia Partners with University of South Australia’s Electric Formula SAE Program

Sep 16 2021 - PR NewsWire

Panduit Australia partners up with UniSA Electric Vehicle Program, supporting green energy solutions and local engineering grass routs development MELBOURNE,…


Orangeleaf Consulting realises education innovation with AtOnce.biz for its Australian debut

Sep 16 2021 - PR NewsWire

KUALA LUMPUR, Malaysia and SYDNEY, Sept. 16, 2021 /PRNewswire/ — Digital innovation service provider specialised in Mendix Low-Code, Orangeleaf Consulting will…


SuperTrans Medical supported by U.S. National Institutes of Health (NIH) in developing its lead antibiotic against urgent threat drug resistant bacteria

Sep 16 2021 - PR NewsWire

SYDNEY, Sept. 16, 2021 /PRNewswire/ — SuperTrans Medical ("STM"), a biopharmaceutical company developing novel antibiotics that target difficult-to-treat, multi-drug resistant…


US Patent and Trademark Office grants new patent for DEP® cabazitaxel, one of Starpharma’s phase 2 clinical-stage cancer treatments

Sep 15 2021 - PR NewsWire

MELBOURNE, Australia, Sept. 15, 2021 /PRNewswire/ — DEP® cabazitaxel is a proprietary nanoparticle version of leading prostate cancer drug cabazitaxel (Jevtana®), which…


Humanforce Releases Solution to Help Employers Manage COVID-19 Vaccination Policies

Sep 15 2021 - PR NewsWire

Solution streamlines vaccine policy communication and tracking, after employees say they want their colleagues to be vaccinated SYDNEY, Sept. 15,…


Cappfinity supports post-pandemic workforce transformation with innovative strengths-based Talent Practice

Sep 14 2021 - PR NewsWire

LONDON, Sept. 14, 2021 /PRNewswire/ — HR tech firm, Cappfinity, has launched a global Talent Practice to support businesses through…


New Therapy to Treat Advanced Small Cell Lung Cancer Approved for Australian Patients

Sep 14 2021 - PR NewsWire

Highlights: ZEPZELCA® (lurbinectedin) is the first new therapy approved to treat second-line metastatic SCLC in Australia in more than 20…


Analyse The Market From A Different Angle